MetaCap

Natera (NTRA) vs UnitedHealth Group (UNH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Natera (NTRA) has outperformed UnitedHealth Group (UNH) over the past year, gaining 127.1% versus a gain of 0.3%. Over five years, NTRA leads with a +252.8% price change compared with -13.3% for UNH. UnitedHealth Group is the larger company by market cap ($340.46 billion vs $57.76 billion), about 5.9 times the size, while Natera is growing revenue faster (+35.9% vs +11.8%).

UnitedHealth Group pays a dividend yielding 2.36%, while Natera does not currently pay one. UnitedHealth Group converts more of its revenue into profit, with a net margin of 2.7% versus -9.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NTRA+127.08%UNH+0.28%
+156%+59%-39%
Oct 8, 20251 yearOct 8, 2026
NTRA+242.59%UNH-9.18%
+278%+96%-87%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NTRA versus UNH key metrics
MetricNTRAUNH
Share price$400.71$379.30
Market cap$57.76B$340.46B
1-day change+2.54%+2.25%
YTD return+70.58%+12.37%
1-year return+127.08%+0.28%
5-year return+252.79%-13.34%
P/E ratio (TTM)—24.39
Forward P/E—16.78
EPS (TTM)$-1.35$15.55
Dividend yield0.00%2.36%
Annual dividend$0.00$8.95
Revenue (latest FY)$2.31B$447.57B
Revenue growth (YoY)+35.90%+11.81%
Net income (latest FY)$-208.16M$12.06B
Gross margin—88.68%
Operating margin-13.44%4.24%
Net margin-9.03%2.69%
52-week high$437.41$461.62
52-week low$167.99$255.97
Distance from 52-week high-8.39%-17.83%
Analyst consensusstrong_buybuy
Avg. price target upside-5.81%+27.00%
Average volume1.45M4.94M
Shares outstanding144.14M897.59M
Employees6,135390,000
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • UnitedHealth Group is about 5.9 times larger than Natera by market value ($340.46B vs $57.76B).
  • NTRA has outperformed UNH by 126.8 percentage points over the past year.
  • UnitedHealth Group offers a meaningfully higher dividend yield (2.36% vs 0.00%).
  • UnitedHealth Group is more profitable, keeping 2.7 cents of every revenue dollar as net income versus -9.0 cents for Natera.
  • Natera grew revenue faster in its latest fiscal year (+35.90% vs +11.81%).

About Natera

NTRA stock →

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.

Health Care · Medical Specialities · 6,135 employees

About UnitedHealth Group

UNH stock →

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.

Health Care · Medical Specialities · 390,000 employees

NTRA vs UNH FAQ

Which is bigger, Natera or UnitedHealth Group?

UnitedHealth Group (UNH) is larger, with a market capitalization of $340.46B compared with $57.76B for Natera (NTRA).

Which stock has performed better over the past year, NTRA or UNH?

NTRA returned +127.08% over the past 12 months, compared with +0.28% for UNH (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Natera or UnitedHealth Group?

UnitedHealth Group pays a dividend yielding 2.36%, while Natera does not currently pay a regular dividend.

Are Natera and UnitedHealth Group in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons